GLP-1 Receptor Agonist Risks: Why Stopping Treatment Matters
Comments Off on GLP-1 Receptor Agonist Risks: Why Stopping Treatment Matters
April 20, 2026
GLP-1 receptor agonist psychiatric safety is a critical consideration when stopping treatment. Abrupt discontinuation can lead to mood disturbances and metabolic rebound. Clinicians must counsel patients on these risks to ensure safe management.
Can CBD Gummies Make You Depressed? Insights from Pathologica
Comments Off on Can CBD Gummies Make You Depressed? Insights from Pathologica
April 16, 2026
CBD depression drug safety dosing is a critical topic for clinicians and patients alike. Current evidence shows mixed effects of CBD on mood, requiring careful monitoring. Understanding dosing and product quality is essential to avoid worsening…
Cannabis and Mental Health: Why ‘Cannabis’ and ‘d9-THC’ Are Not the Same
Comments Off on Cannabis and Mental Health: Why ‘Cannabis’ and ‘d9-THC’ Are Not the Same
March 30, 2026
Cannabis mental health risk factors depend heavily on cannabinoid exposure, especially THC and CBD ratios. Understanding these factors is essential for assessing psychiatric outcomes. This article clarifies why cannabis and d9-THC are not interchangeable…